BHALCHANDRA BARVE
-
Collaborations can establish supportive ecosystem for research, innovation, manufacturing of high-value pharmaceuticals
Focusing on the imperative to move from volume-centric practices to value-based processes, the Re-Pharma Summit 2024 featured prominent industry figures discussing key insights, initiatives, and the vision to position India as a global leader in the pharmaceutical domain by 2047. The summit commenced with a panel discussion on ‘Volume-to-Value in the Indian Pharmaceutical Ecosystem’.
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
